Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

In a fresh appearance on CNBC’s Squawk Box this morning, Baron said he does not expect to sell his personal Tesla or SpaceX shares during his lifetime, underscoring just how long-term his conviction really is. The interview, which is being widely syndicated through outlets including MSN and YouTube, also touched on the broader stock market, Musk’s record-breaking $1 trillion Tesla pay package, and what investors can expect from today’s 32nd Annual Baron Investment Conference in New York. StockAnalysis+2YouTube+2
14 November 2025
···
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4
14 November 2025
··
Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms 2026 Space Tourism Launch as Stock Trades Near Lows

Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms 2026 Space Tourism Launch as Stock Trades Near Lows

Virgin Galactic Holdings, Inc. is back in the headlines today after releasing its third‑quarter 2025 results last night and updating investors on progress toward its long‑promised space tourism service. The company is still burning a lot of cash and generating almost no revenue, but it narrowed its quarterly loss, shored up liquidity, and reaffirmed a late‑2026 launch timeline for private astronaut flights. Virgin Galactic+1
14 November 2025
···
Avelo Airlines Unveils $34–$35 Flights From Detroit, Wilmington and Concord for Spring 2026

Avelo Airlines Unveils $34–$35 Flights From Detroit, Wilmington and Concord for Spring 2026

Avelo Airlines is betting big on the eastern U.S. this week, rolling out ultra-cheap fares and six new or returning routes that tie together Detroit, Wilmington and Concord with Atlanta, Chicago, Nashville and Central Florida. Sale prices start as low as $34 one way from Detroit to Orlando/Lakeland, Florida and $35 from Concord to Chicago and Nashville, according to airline and local-government announcements and today’s coverage in the Detroit Free Press. Avelo Airlines+2Detroit Free Press+2
14 November 2025
IREN Stock Falls on November 13 as Market Questions Earnings Quality After Record Q1 and $9.7B Microsoft AI Cloud Deal

IREN Stock Falls on November 13 as Market Questions Earnings Quality After Record Q1 and $9.7B Microsoft AI Cloud Deal

Shares of IREN Limited – the bitcoin‑miner‑turned‑AI‑data‑center operator – are sliding today as fresh commentary about the “quality” of its blockbuster earnings collides with a sharp technical sell‑off after last week’s euphoria around its $9.7 billion Microsoft AI cloud contract. IREN+2Reuters+2
13 November 2025
··
D-Wave Quantum (QBTS) Stock Plunges as Short Sellers Circle and Institutions Buy – All the Key News on 13 November 2025

D-Wave Quantum (QBTS) Stock Plunges as Short Sellers Circle and Institutions Buy – All the Key News on 13 November 2025

As of Thursday, 13 November 2025, D-Wave Quantum Inc. is back in the spotlight – and not in a calm way. The quantum computing pioneer’s stock is sliding sharply again, even as big-name investors file new stakes and the media debate whether the recent boom in quantum stocks is a bubble or a once‑in‑a‑generation opportunity.
13 November 2025
··
1 … 50 51 52 53 54 … 164

Stock Market Today

  • Revolution Medicines (RVMD) Shares Trade at a Premium Despite Robust Gains
    July 25, 2026, 2:47 PM EDT. Revolution Medicines (RVMD) shares have jumped with a 399.2% return over the past year and approximately 6.4x growth in three years, though the stock's valuation is considered steep. With a P/B ratio of 26.8x, Revolution Medicines is well above the Biotech sector's 2.5x average and peer level of 10.3x. The stock meets just 2 out of 6 valuation criteria, indicating a premium linked to its FDA-reviewed drug daraxonrasib and data from its pancreatic cancer trial, along with concerns tied to regulatory risk.